Ramesh Kurukulaaratchy
Overview
Explore the profile of Ramesh Kurukulaaratchy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Freeman A, Minnion M, Lee P, Haitchi H, Kurukulaaratchy R, Wilkinson T, et al.
Allergy
. 2024 Dec;
PMID: 39698749
No abstract available.
2.
Graham E, Eames C, Soe W, Fox L, Whitfield C, Kerley S, et al.
ERJ Open Res
. 2024 Dec;
10(6).
PMID: 39687394
https://bit.ly/4cgrJEL.
3.
Djukanovic R, Brinkman P, Kolmert J, Gomez C, Schofield J, Brandsma J, et al.
Am J Respir Crit Care Med
. 2024 Apr;
210(3):288-297.
PMID: 38635834
The anti-IgE monoclonal antibody omalizumab is widely used for severe asthma. This study aimed to identify biomarkers that predict clinical improvement during 1 year of omalizumab treatment. One-year open-label Study...
4.
Kadalayil L, Lowther S, Fong W, Nicolas F, Potter S, Larsson M, et al.
Clin Exp Allergy
. 2024 Feb;
54(5):350-352.
PMID: 38317332
No abstract available.
5.
Bossios A, Bacon A, Eger K, Paroczai D, Schleich F, Hanon S, et al.
ERJ Open Res
. 2023 Nov;
9(6).
PMID: 38020570
Background: Vaccination is vital for achieving population immunity to severe acute respiratory syndrome coronavirus 2, but vaccination hesitancy presents a threat to achieving widespread immunity. Vaccine acceptance in chronic potentially...
6.
Malik M, Jones B, Williams E, Kurukulaaratchy R, Holroyd C, Mason A
Rheumatol Adv Pract
. 2023 Feb;
7(1):rkad018.
PMID: 36789243
Objective: Combination biological therapies are being considered increasingly for patients with multiple co-morbidities requiring biologics. There are limited data available on this approach, and concerns remain about the possible risk...
7.
Fong W, Kadalayil L, Lowther S, Grevatt S, Potter S, Tidbury T, et al.
Ann Allergy Asthma Immunol
. 2022 Oct;
130(2):199-205.e2.
PMID: 36288782
Background: Air pollution is associated with poor asthma outcomes. High-efficiency particulate air air purifiers may reduce air pollution and thus improve asthma outcomes. However, the efficacy of such devices for...
8.
Eger K, Paroczai D, Bacon A, Schleich F, Sergejeva S, Bourdin A, et al.
ERJ Open Res
. 2022 May;
8(2).
PMID: 35582679
Background: The coronavirus disease 2019 (COVID-19) pandemic has put pressure on healthcare services, forcing the reorganisation of traditional care pathways. We investigated how physicians taking care of severe asthma patients...
9.
Barber C, Azim A, Newell C, Kyyaly A, Rupani H, Haitchi H, et al.
Clin Exp Allergy
. 2022 Feb;
52(6):792-796.
PMID: 35152508
No abstract available.
10.
Fong W, Grevatt S, Potter S, Tidbury T, Kadalayil L, Bennett K, et al.
JMIR Res Protoc
. 2021 Jul;
10(7):e28624.
PMID: 34313599
Background: Indoor air quality has been shown to influence asthma control and outcomes. Air purifiers and high-efficiency particulate air filtration devices can improve indoor air quality by reducing the indoor...